Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04592913 |
|---|---|
| Brief Title: | Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer |
| First Submitted : | August 26, 2020 |
| First Submitted that Met QC Criteria : | October 13, 2020 |
| First Posted : | October 19, 2020 |
| Last Update Submitted that Met QC Criteria : | March 16, 2023 |
| Last Update Posted : | March 17, 2023 (Estimate) |